Immunogenicity and Safety of Defective Vaccinia Virus Lister: Comparison with Modified Vaccinia Virus Ankara
Potent and safe vaccinia virus vectors inducing cell-mediated immunity are needed for clinical use. Replicating vaccinia viruses generally induce strong cell-mediated immunity; however, they may have severe adverse effects. As a vector for clinical use, we assessed the defective vaccinia virus syste...
Guardat en:
| Publicat a: | J Virol |
|---|---|
| Autors principals: | , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society for Microbiology (ASM)
2002
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC136372/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12097585/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/JVI.76.15.7713-7723.2002 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|